Gene Mannheimer analyst FREEDOM CAPITAL MARKETS

Currently out of the existing stock ratings of Gene Mannheimer, 14 are a BUY (70%), 6 are a HOLD (30%).

Gene Mannheimer

Work Performance Price Targets & Ratings Chart

Analyst Gene Mannheimer, currently employed at FREEDOM CAPITAL MARKETS, carries an average stock price target met ratio of 61.54% that have a potential upside of 11.14% achieved within 134 days. Previously, Gene Mannheimer worked at COLLIERS, TOPEKA.

Gene Mannheimer’s has documented 52 price targets and ratings displayed on 4 stocks. The coverage is on the Technology sector.

Most recent stock forecast was given on IRTC, iRhythm Technologies at 26-Feb-2021.

Wall Street Analyst Gene Mannheimer

Analyst best performing recommendations are on IRTC (IRHYTHM TECHNOLOGIES).
The best stock recommendation documented was for CPSI (COMPUTER PROGRAMS AND SYSTEMS) at 10/30/2015. The price target of $43 was fulfilled within 26 days with a profit of $9.71 (29.17%) receiving and performance score of 11.22.

Average potential price target upside

AMEH Apollo Medical Holdings MDSO Medidata Solutions MEDS Trxade Group VCRA Vocera Communications

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 12-Apr-2023

$55

$18.28 (49.78%)

$44

2 years 4 months 16 days ago
(22-Feb-2024)

1/2 (50%)

$13.3 (31.89%)

323

Buy Since 19-Dec-2022

$60

$23.28 (63.40%)

$40

3 years 4 months 11 days ago
(27-Feb-2023)

1/2 (50%)

$24.75 (70.21%)

115

Hold Since 08-Aug-2022

$57

$20.28 (55.23%)

$92

3 years 11 months ago
(08-Aug-2022)

1/2 (50%)

$4.05 (7.65%)

29

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Gene Mannheimer?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?